External Validation of Uromonitor as a Biomarker for Optimization of NMIBC Management by the CUETO Group
Active, not recruiting
- Conditions
- Non-muscle-invasive Bladder Cancer
- First Posted Date
- 2023-05-18
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Pharmalink
- Target Recruit Count
- 600
- Registration Number
- NCT05864599
- Locations
- 🇪🇸
Hospital Vithas 9 d'Octubre, Valencia, Spain